Abstract
This study was carried out to investigate the efficacy and safety of high-dose chemotherapy (HDC) for the treatment of patients with advanced testicular cancer. Seven patients were treated with high-dose carboplatin, etoposide, and ifosfamide followed by autologous blood stem cell transplantation. One patient received 1 cycle, 4 patients received 2 cycles, and 2 patients received 3 cycles of HDC. We performed a total of 15 autologous blood stem cell transplantations: 8 with autologous bone marrow; 6 with peripheral blood stem cells; and 1 with peripheral blood stem cells in addition to autologous bone marrow. Four of the 7 patients achieved a pathologic complete response via early use of HDC and additional salvage surgery. All 4 patients are still alive without evidence of disease at 12, 30, 33, and 54 months, respectively. One patient is alive with active disease at 35 months. Two patients refractory to conventional chemotherapy died of progressive disease at 5 and 27 months, respectively. The hematologic recovery after HDC was rapid, and peripheral blood stem cells tended to have shorter hematologic recovery compared with those from autologous bone marrow, although the difference was not significant. Nonhematologic toxicity w...Continue Reading
References
Jan 15, 1992·Cancer·R J MotzerP Russo
Apr 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C R NicholsD L Trump
Jul 15, 1992·Annals of Internal Medicine·E R BrounG J Tricot
Nov 18, 1992·Journal of the National Cancer Institute·R J Motzer, G J Bosl
Mar 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R BirchF A Greco
Jul 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C R NicholsS N Wolff
Jan 1, 1981·Cancer·A B MillerA Winkler
Mar 15, 1994·Cancer·E R BrounL H Einhorn
Jun 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BeyerW Stieger
Nov 17, 1993·Journal of the National Cancer Institute·R J MotzerG J Bosl
Feb 1, 1995·Cancer·J P LotzV Izrael
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W SiegertD Huhn
Mar 24, 1994·The New England Journal of Medicine·J O Armitage
Oct 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K MargolinM Tetef
Oct 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BeyerW Siegert